Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3121402, 7 pages
http://dx.doi.org/10.1155/2016/3121402
Research Article

Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia

1Department of Clinical Hematology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province 430071, China
2Department of Clinical Hematology, Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, Shaanxi Province 710004, China
3Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province 430071, China

Received 3 July 2016; Revised 13 August 2016; Accepted 17 August 2016

Academic Editor: Michael Silbermann

Copyright © 2016 Honglei Tu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Pulte, A. Gondos, and H. Brenner, “Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010,” Annals of Oncology, vol. 21, no. 2, pp. 335–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Howlader, A. M. Noone, M. Krapcho et al., SEER Cancer Statistics Review, 1975–2009, National Cancer Institute, Bethesda, Md, USA, 2012.
  3. J. M. Vagace and G. Gervasini, “Chemotherapy toxicity in patients with acute leukemia,” in Acute Leukemia—The Scientist's Perspective and Challenge, M. Antica, Ed., chapter 17, InTech, Rijeka, Croatia, 2011. View at Publisher · View at Google Scholar
  4. “Challenges in research and development of traditional chinese medicines,” Chinese Herbal Medicines, no. 1, pp. 1–28, 2009.
  5. Q. Ji, Y. Luo, W. Wang, X. Liu, Q. Li, and S. Su, “Research advances in traditional Chinese medicine syndromes in cancer patients,” Journal of Integrative Medicine, vol. 14, no. 1, pp. 12–21, 2016. View at Publisher · View at Google Scholar
  6. C.-L. Qian, F. Yan, Y.-Z. Song, D. Li, K.-Z. Dong, and Y.-M. Zhu, “Is the traditional Chinese medicine helpful for patients with hematologic malignant diseases? A meta-analysis of randomized controlled trials,” World Journal of Meta-Analysis, vol. 3, no. 3, pp. 163–180, 2015. View at Publisher · View at Google Scholar
  7. Z. Liu, S. Chen, J. Cai et al., “Traditional Chinese Medicine syndrome-related herbal prescriptions in treatment of malignant tumors,” Journal of Traditional Chinese Medicine, vol. 33, no. 1, pp. 19–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tian, W.-H. Wang, H.-M. Cao, and Z.-M. Wang, “Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC,” China Journal of Chinese Materia Medica, vol. 32, no. 3, pp. 222–224, 2007. View at Google Scholar · View at Scopus
  9. Q. I. Liang, J. Zhang, and Z. Zhang, “Determination of four alkaloids in compound Kushen Injection by high performance liquid chromatography with ionic liquid as mobile phase additive,” Chinese Journal of Chromatography, vol. 31, no. 3, pp. 249–253, 2013. View at Google Scholar
  10. Z. Z. Qian, Y. Dan, Y. Z. Liu, and Y. Peng, “Pharmacopoeia of the People's Republic of China (2010 edition): a milestone in development of China's healthcare,” Chinese Herbal Medicines, vol. 2, no. 2, pp. 157–160, 2010. View at Google Scholar
  11. M. Sun, H. Cao, L. Sun et al., “Antitumor activities of kushen: literature review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 373219, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Ma, R.-S. Li, J. Wang et al., “The therapeutic efficacy and safety of compound kushen injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: an update systematic review and meta-analysis,” Frontiers in Pharmacology, vol. 7, article 70, 2016. View at Publisher · View at Google Scholar
  13. W. Xu, H. Lin, Y. Zhang et al., “Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway,” Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Yin, W. L. Zheng, Q. Z. Sun, Y. F. Peng, and M. A. Wen-Li, “Meta-analysis of efficiency in treatment of gastric cancer by compound Kushen injection combined with chemotherapy,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 14, pp. 325–330, 2013. View at Publisher · View at Google Scholar
  15. Z. Y. Wang, G. S. Li, and H. X. Huang, “Clinical observation on treatment of 75 mid-late stage cancer patients with Yanshu injection,” Chinese Journal of Integrated Traditional & Western Medicine, vol. 26, no. 8, pp. 681–684, 2006. View at Google Scholar
  16. J. Chen, Q. Mei, Y.-C. Xu, J. Du, Y. Wei, and Z.-M. Xu, “Effects of Matrine injection on T-lymphocyte subsets of patients with malignant tumor after gamma knife radiosurgery,” Journal of Chinese Integrative Medicine, vol. 4, no. 1, pp. 78–79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Yanju, L. Yang, B. Hua et al., “A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain,” Supportive Care in Cancer, vol. 22, no. 3, pp. 825–836, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Guerretta, “Common Terminology Criteria for Adverse Events v3.0 (CTCAE),” 2003.
  19. R. Guangxin, L. I. Hegen, L. Zhao, L. Liu, L. Shen, and L. Zhou, “Effect of method of strengthening genuine qi on tumor microenvironment of advanced non-small cell lung cancer,” Journal of Liaoning University of Traditional Chinese Medicine, no. 6, pp. 157–159, 2013. View at Google Scholar
  20. M. Xu, G. Zhang, L. Pan et al., “Effects of Chinese herbs of strengthening and invigorating genuine Qi on multidrug resistant lung cancer cells through regulation of mitochondria related molecules,” Chinese Journal of Clinical Oncology, vol. 37, no. 13, pp. 725–728, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. R. Corces-Zimmerman and R. Majeti, “Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis,” Leukemia, vol. 28, no. 12, pp. 2276–2282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kanji, V. J. Pompili, and H. Das, “Plasticity and maintenance of hematopoietic stem cells during development,” Recent Patents on Biotechnology, vol. 5, no. 1, pp. 40–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Nazha and F. Ravandi, “Acute myeloid leukemia in the elderly: do we know who should be treated and how?” Leukemia & Lymphoma, vol. 55, no. 5, pp. 979–987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Rébé and F. Ghiringhelli, “Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies?” Future Oncology, vol. 11, no. 19, pp. 2645–2654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. R. G. van der Most, A. Currie, B. W. S. Robinson, and R. A. Lake, “Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity,” Cancer Research, vol. 66, no. 2, pp. 601–604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Olioso, R. Giancola, M. Di Riti, A. Contento, P. Accorsi, and A. Iacone, “Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial,” Hematological Oncology, vol. 27, no. 3, pp. 130–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Alanko, T.-T. Pelliniemi, and T. T. Salmi, “Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia,” Cancer, vol. 69, no. 6, pp. 1481–1486, 1992. View at Google Scholar · View at Scopus
  28. X. Liu, H. Li, L. Wu et al., “Simultaneous quantification of chrysophanol and physcion in rat plasma by ultra fast liquid chromatography-tandem mass spectrometry and application of the technique to comparative pharmacokinetic studies of Radix et Rhei Rhizoma extract alone and Dahuang Fuzi Decoction,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 980, pp. 88–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Jin, C. Qu, Y. Tang et al., “Herb pairs containing Angelicae Sinensis Radix (Danggui): a review of bio-active constituents and compatibility effects,” Journal of Ethnopharmacology, vol. 181, pp. 158–171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. K. Drew, A. Bensoussan, I. M. Whyte, A. H. Dawson, X. Zhu, and S. P. S. Myers, “Chinese herbal medicine toxicology database: monograph on Radix Sophorae Flavescentis, ‘Ku Shen’,” Journal of Toxicology: Clinical Toxicology, vol. 40, no. 2, pp. 173–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. G. P. Zhang, S. H. Xie, X. G. Zhu et al., “Experimental study on effects of radix glycyrrhizae on toxicity and efficacy of radix aconiti carmichaeli in compatibility,” Chinese Journal of Information on Traditional Chinese Medicine, no. 6, pp. 31–34, 2012. View at Google Scholar
  32. J. Y. Lee, J.-H. Lee, J. H. Park et al., “Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not,” International Immunopharmacology, vol. 9, no. 5, pp. 632–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-W. Shin, E.-A. Bae, B. Lee et al., “In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components,” Planta Medica, vol. 73, no. 3, pp. 257–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. C. Kim, S. H. Byun, C. H. Yang, C. Y. Kim, J. W. Kim, and S. G. Kim, “Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage),” Toxicology, vol. 197, no. 3, pp. 239–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Shi, X. Tang, X. Dang et al., “Investigating herb-herb interactions: the potential attenuated toxicity mechanism of the combined use of Glycyrrhizae radix et rhizoma (Gancao) and Sophorae flavescentis radix (Kushen),” Journal of Ethnopharmacology, vol. 165, pp. 243–250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Wang, X. Huang, N. Wang et al., “Toxicity of the water extraction of radix sophorae flavescentis formulated with radix glycyrrhizae on mice,” Chinese Archives of Traditional Chinese Medicine, vol. 33, no. 7, pp. 1653–1655, 2015. View at Google Scholar